ticlopidine has been researched along with zolmitriptan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baudoin, Y; Guilhem, K; Meyrat, L; Thouard, H | 1 |
1 review(s) available for ticlopidine and zolmitriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ticlopidine and zolmitriptan
| Article | Year |
|---|---|
Images of an occlusive arterial disease of lower extremity due to chronic intoxication by ergot alkaloid.
Topics: Arterial Occlusive Diseases; Clopidogrel; Drug Substitution; Female; Humans; Lower Extremity; Methysergide; Middle Aged; Migraine Disorders; Oxazolidinones; Platelet Aggregation Inhibitors; Predictive Value of Tests; Serotonin 5-HT1 Receptor Agonists; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tryptamines; Vasoconstrictor Agents | 2014 |